...
首页> 外文期刊>ACS Central Science >Injectable Slippery Lubricant-Coated Spiky Microparticles with Persistent and Exceptional Biofouling-Resistance
【24h】

Injectable Slippery Lubricant-Coated Spiky Microparticles with Persistent and Exceptional Biofouling-Resistance

机译:具有持久性和卓越的抗生物污垢性的可注射滑润剂涂层的尖刺微粒

获取原文

摘要

Injectable micron-sized particles have historically achieved promising applications, but they continued to suffer from long-term biofouling caused by the adhesions of biomolecules, cells, and bacteria. Recently, a slippery lubricant infusion porous substrate (SLIPS) exhibited robust antiadhesiveness against many liquids; however, they were constructed using a 2D substrate, and they were not suitable for in vivo applications, such as injectable biomaterials. Inspired by SLIPS, here, we report the first case of injectable solid microparticles coated with a lubricating liquid surface to continuously resist biofouling. In our design, microparticles were attached with nanospikes and fluorinated to entrap the lubricant. The nanospikes enabled the lubricant-coated spiky microparticles (LCSMPs) to anomalously disperse in water despite the attraction between the surfaces of the microparticles. This result indicated that the LCSMPs exhibited persistent anomalous dispersity in water while maintaining a robust lubricating surface layer. LCSMPs prevented the adhesion of proteins, mammalian cells, and bacteria, including Escherichia coli and Staphylococcus aureus. LCSMPs also reduced in vivo fibrosis while conventional microparticles were heavily biofouled. This technology introduced a new class of injectable anti-biofouling microparticles with reduced risks of inflammation and infections.
机译:从历史上看,可注射的微米级颗粒已获得了有希望的应用,但由于生物分子,细胞和细菌的粘附,它们仍长期遭受长期的生物污染。近来,光滑的润滑剂注入多孔基材(SLIPS)对许多液体表现出强大的抗粘着性。但是,它们是使用2D基材构建的,因此不适合用于体内应用程序,例如可注射生物材料。受SLIPS的启发,我们在此报告了第一例可注射的固体微粒,该微粒涂覆有润滑性液体表面以连续抵抗生物结垢。在我们的设计中,微粒被纳米钉附着并被氟化以捕获润滑剂。尽管微粒表面之间具有吸引力,但纳米钉使润滑剂涂覆的尖刺微粒(LCSMP)异常分散在水中。该结果表明,LCSMP在水中表现出持久的异常分散性,同时保持了坚固的润滑表面层。 LCSMPs阻止了蛋白质,哺乳动物细胞和细菌(包括大肠杆菌和金黄色葡萄球菌)的粘附。 LCSMPs还减少了体内纤维化,而常规微粒被严重生物污染。这项技术引入了新型的可注射的抗生物结垢微粒,可降低发炎和感染的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号